Clonidine Hydrochloride Tablet
FDA Label NDC 55154-2576

20 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Clonidine Hydrochloride (NDC 55154-2576). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, pharmacokinetics:, indications and usage, contraindications, withdrawal:, general:, perioperative use:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-2576-0

CLONIDINE HYDROCHLORIDE

TABLETS, USP 0.1 mg

10 TABLETS

0.1mg Bag Label (16c59ca8 Fc05 De71 E063 6294a90ab3fc 01)

0.1mg Bag Label (16c59ca8 Fc05 De71 E063 6294a90ab3fc 01)

NDC 55154-2577-0

CLONIDINE HYDROCHLORIDE

TABLETS, USP 0.2 mg

10 TABLETS

0.2mg Bag Label (16c59ca8 Fc05 De71 E063 6294a90ab3fc 00)

0.2mg Bag Label (16c59ca8 Fc05 De71 E063 6294a90ab3fc 00)

* Please review the disclaimer below.